Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)
- PMID: 7550340
- DOI: 10.1038/ng1095-137
Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)
Abstract
Hereditary multiple exostoses is an autosomal dominant disorder that is characterized by short stature and multiple, benign bone tumours. In a majority of families, the genetic defect (EXT1) is linked to the Langer-Giedion syndrome chromosomal region in 8q24.1. From this region we have cloned and characterized a cDNA which spans chromosomal breakpoints previously identified in two multiple exostoses patients. Furthermore, the gene harbours frameshift mutations in affected members of two EXT1 families. The cDNA has a coding region of 2,238 bp with no apparent homology to other known gene sequences and thus its function remains elusive. However, recent studies in sporadic and exostosis-derived chondrosarcomas suggest that the 8q24.1-encoded EXT1 gene may have tumour suppressor function.
Similar articles
-
The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.Nat Genet. 1996 Sep;14(1):25-32. doi: 10.1038/ng0996-25. Nat Genet. 1996. PMID: 8782816
-
Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.Hum Mutat. 1998;11(3):231-9. doi: 10.1002/(SICI)1098-1004(1998)11:3<231::AID-HUMU8>3.0.CO;2-K. Hum Mutat. 1998. PMID: 9521425
-
[From gene to disease; hereditary multiple exostoses].Ned Tijdschr Geneeskd. 2002 Jan 26;146(4):162-4. Ned Tijdschr Geneeskd. 2002. PMID: 11845565 Review. Dutch.
-
The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.Nat Genet. 1998 Jun;19(2):158-61. doi: 10.1038/514. Nat Genet. 1998. PMID: 9620772
-
Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.Hum Mutat. 2000;15(3):220-7. doi: 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K. Hum Mutat. 2000. PMID: 10679937 Review.
Cited by
-
Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.Virchows Arch. 2012 Oct;461(4):475-81. doi: 10.1007/s00428-012-1300-5. Epub 2012 Aug 18. Virchows Arch. 2012. PMID: 22903264
-
A Genotype-Phenotype Study of Multiple Hereditary Exostoses in Forty-Three Patients.J Clin Med. 2022 Jun 27;11(13):3703. doi: 10.3390/jcm11133703. J Clin Med. 2022. PMID: 35806987 Free PMC article.
-
Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostics, and Potential Therapeutic Strategies.Front Genet. 2021 Dec 10;12:759129. doi: 10.3389/fgene.2021.759129. eCollection 2021. Front Genet. 2021. PMID: 34956317 Free PMC article. Review.
-
Interpreting cDNA sequences: some insights from studies on translation.Mamm Genome. 1996 Aug;7(8):563-74. doi: 10.1007/s003359900171. Mamm Genome. 1996. PMID: 8679005 Review.
-
Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.PLoS Genet. 2017 Apr 26;13(4):e1006742. doi: 10.1371/journal.pgen.1006742. eCollection 2017 Apr. PLoS Genet. 2017. PMID: 28445472 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous